Changes in subcellular localisation of MI-ER1α, a novel oestrogen receptor-α interacting protein, is associated with breast cancer progression

British Journal of Cancer

Volumn 99, Issue 4, 2008, Pages 639-646

  McCarthy, P L ^a   Mercer, F C ^a   Savicky, M W J ^a   Carter, B A ^a   Paterno, G D ^a   Gillespie, L L ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Breast carcinoma; Immunohistochemistry; LXXLL motif; MI ER1; Nuclear localisation; Oestrogen receptor

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR 1 ALPHA; ESTROGEN RECEPTOR ALPHA; LIGAND;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BREAST; BREAST CARCINOMA; CANCER GROWTH; CANCER INVASION; CARCINOMA CELL; CELL LINE; CELL PROLIFERATION; CELL STRAIN HEK293; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; EMBRYO; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VIVO STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN INTERACTION; REGULATORY MECHANISM; SAMPLE; STAINING; TISSUE MICROARRAY; TISSUE SECTION;

ADULT; AGED; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; CYTOPLASM; DISEASE PROGRESSION; DOXYCYCLINE; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; KIDNEY; MIDDLE AGED; NUCLEAR PROTEINS; SUBCELLULAR FRACTIONS; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS;

EID: 49549114024     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604518     Document Type: Article

References (24)

1. Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL (1993) Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Instit 85: 200-206
2. Anderson E (2002) The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res 4: 197-201
3. Arnedos M, Smith I (2007) Progression of endocrine therapies for breast cancer: where are we headed? Expert Rev Anticancer Ther 7: 1651-1664
4. Ascenzi P, Bocedi A, Marino M (2006) Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med 27: 299-402
5. Chen JD, Evans RM (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454-457
6. Clarke RB, Anderson E, Howell A (2004) Steroid receptors in human breast cancer. Trends Endocrinol Metabol 15: 316-323
7. Ding Z, Gillespie LL, Mercer FC, Paterno GD (2004) The SANT domain of human MI-ER1 interacts with Sp1 to interfere with GC box recognition and repress transcription from its own promoter. J Biol Chem 279: 28009-28016
8. Ding Z, Gillespie LL, Paterno GD (2003) Human MI-ER1 alpha and beta function as transcriptional repressors by recruitment of histone deacetylase 1 to their conserved ELM2 domain. Mol Cell Biol 23: 250-258
9. Dobrzycka KM, Townson SM, Jiang S, Oesterreich S (2003) Estrogen receptor corepressors - a role in human breast cancer? Endocr Relat Cancer 10: 517-536
10. Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM (2001) Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene 20: 77-87
11. Fernandes I, Bastien Y, Wai T, Nygard K, Lin R, Cormier O, Lee HS, Eng F, Bertos NR, Pelletier N, Mader S, Han VK, Yang XJ, White JH (2003) Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol Cell 11: 139-150
12. Hall JM, McDonnell DP (2005) Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. Mol Interv 5: 343-357
13. Harvey JM, Clark GM, Osborne CK, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17: 1474-1481
14. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397-404
15. Kumar R, Wang R-A, Mazumdar A, Talukder AH, Mandal M, Yang Z, Bagheri-Yarmand R, Sahin A, Hortobagyi G, Adam L, Barnes CJ, Vadlamudi RK (2002) A naturally occurring MTA1 variant sequesters oestrogen receptor-[alpha] in the cytoplasm. Nature 418: 654-657
16. Manavathi B, Kumar R (2007) Metastasis tumor antigens, an emerging family of multifaceted master coregulators. J Biol Chem 282: 1529-1533
17. Paterno GD, Ding Z, Lew YY, Nash GW, Mercer FC, Gillespie LL (2002) Genomic organization of the human mi-er1 gene and characterization of alternatively spliced isoforms: regulated use of a facultative intron determines subcellular localization. Gene 295: 79-88
18. Paterno GD, Li Y, Luchman HA, Ryan PJ, Gillespie LL (1997) cDNA cloning of a novel, developmentally regulated immediate early gene activated by fibroblast growth factor and encoding a nuclear protein. J Biol Chem 272: 25591-25595
19. Paterno GD, Mercer FC, Chayter JJ, Yang X, Robb JD, Gillespie LL (1998) Molecular cloning of human er1 cDNA and its differential expression in breast tumours and tumour-derived cell lines. Gene 222: 77-82
20. Rosen EM, Fan S, Isaacs C (2005) BRCA1 in hormonal carcinogenesis: basic and clinical research. Endocr Relat Cancer 12: 533-548
21. Ryan PJ, Gillespie LL (1994) Phosphorylation of phospholipase C gamma 1 and its association with the FGF receptor is developmentally regulated and occurs during mesoderm induction in Xenopus laevis. Dev Biol 166: 101-111
22. Thorne LB, Grant AL, Paterno GD, Gillespie LL (2005) Cloning and characterization of the mouse ortholog of mi-er1. DNA Seq 16: 237-240
23. Thorne LB, McCarthy PL, Paterno GD, Gillespie LL (2008) Protein expression of the transcriptional regulator MI-ER1 alpha in adult mouse tissues. J Mol Histol 39: 15-24
24. Wiechmann L, Kuerer HM (2008) The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer 112: 2130-2142